BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service.
CNS biotech Myrobalan Therapeutics raises $24M Series A to enter the clinic
Myrobalan Therapeutics has raised $24 million to enter the clinic with one of its four CNS therapeutic candidates, with the goal of either repairing or